PANTOPRAZOLE-AFT POWDER FOR INJECTION 40MG/VIAL

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

**4.2 POSOLOGY AND METHOD OF ADMINISTRATION** The intravenous administration of pantoprazole is recommended only if oral application is not appropriate.  **Special patient population** **_Paediatric patients_** The experience in children is limited. Pantoprazole-AFT powder for solution for injection is not recommended for use in patients below 18 years of age. **_Impaired hepatic function_** A daily dose of pantoprazole 20 mg should not be exceeded in patients with severe liver impairment (See section 4.4 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). **_Impaired renal function_** No dose adjustment is necessary in those with impaired renal function. **_Elderly patients_** Generally, no dose adjustment is necessary in elderly patients. However, the daily dose of 40 mg should not be exceeded in treatment of gastric or duodenal ulcer.